<DOC>
	<DOCNO>NCT01630863</DOCNO>
	<brief_summary>To find safe effective low light dose photodynamic therapy ( PDT ) . treatment central serous chorioretinopathy .</brief_summary>
	<brief_title>The Safe Effective Light Dose Photodynamic Therapy Chronic Central Serous Chorioretinopathy</brief_title>
	<detailed_description />
	<mesh_term>Central Serous Chorioretinopathy</mesh_term>
	<criteria>1 . Idiopathic detachment neurosensory retina focal leak level RPE FA 2 . Presence SRF and/or serous pigment epithelial detachment optical coherence tomography ( OCT ) 3 . Presence abnormal dilate choroidal vasculature ICGA 4 . Patients symptomatic CSC least 3 month duration 1 . Patients receive previous treatment , include PDT focal thermal laser photocoagulation CSC , evidence CNV , PCV , maculopathy clinical examination , FA , ICGA 2 . Patients receive exogenous corticosteroid treatment 3 . Patients systemic disease Cushing 's disease renal disease 4 . Pregnant patient</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Central serous chorioretinopathy</keyword>
	<keyword>photodynamic therapy</keyword>
	<keyword>safe effective dose</keyword>
</DOC>